Won't be long now until you'll be able to buy stock in Cannabis growth and processing companies. This could be the reason California Politicians are trying to corral the business before people wise up. This November law has been crafted for the State which has fought Cannabis and it will make it a business with penalties that you don't even see yet. You will be closed down to protect the new corporate businesses and the Guards Unions contracts with the Penitentiaries.
16 Canadian Marijuana Stocks
Here's a look at 16 Canadian marijuana stocks, including everything from hemp to high-tech breathalyzers.
« How to Find the Best Cann…
Teresa Matich • June 13, 2016
Add Comment
Best cannabis
Things could be looking up for the cannabis space, and for Canadian marijuana stocks in particular.
At this year’s United Nations General Assembly Special Session (UNGASS 2016), Canadian health minister Jane Philpott announced that the Liberal government intends to introduce legislation to legalize marijuana in spring of 2017. The move gets Canada one step closer to legalizing cannabis for recreational use, a subject that is no doubt top of mind for investors in Canadian marijuana stocks.
A number of states and provinces in Canada and the US are in various phases of legalization for both medical and recreational marijuana use, making the market confusing for new investors. What’s more, the pot bubble of 2014 serves as a good reminder for investors to do careful due diligence on any potential cannabis investment. Still, there are good opportunities out there for interested investors willing to do their research.
With that in mind, here’s a look at a few publicly traded Canadian marijuana stocks. The list includes cannabis and hemp focused stocks listed on Canadian exchanges.
Get Our Expert Guide to Cannabis Investing FREE!
Download this FREE Special Report, Investing in Medical Cannabis Information about Cannabis and Legal Cannabis Stocks.
Canopy Growth (TSXV:CGC)
One of the larger Canadian marijuana stocks, Canopy holds producers Tweed and Bedrocan under its umbrella. Tweed’s production facility is located in the old Hershey factory in Smith Falls, Ontario.
Near the end of May, Bedrocan stated that it would begin offering same-day delivery services in Toronto. Canopy Growth also announced it would be expanding into Australia as well through a partnership with AusCann Group Holdings.
At the start of June, Canopy announced it had received conditional approval to list on the Toronto Stock Exchange.
Mettrum (TSXV:MT)
One of the first medical cannabis producers in Canada to be licensed under MMPR, Mettrum Health is a vertically integrated provider of cannabis products. It operates three facilities in Ontario with an annual production capacity of 12,000 kilograms. Mettrum offers a range of products in both whole-bud and extract forms.
On May 9, the company received an amendment to its license allowing it to both produce and sell medical cannabis and extracts.
OrganiGram (TSXV:OGI)
As its name suggests, OrganiGram specializes in producing organically grown medical marijuana. The company is licensed under MMPR, and has a production facility located in Moncton, New Brunswick. On June 2, Organigram closed a $10 million bought deal financing and announced the appointment of Peter Amirault to the company’s board of directors.
Aphria (TSXV:APH)
Also licensed under MMPR, Aphria is located in Learnington Ontario, at “Canada’s southernmost point.” The company announced on June 2 that it expects to more than double its growing capacity—the company’s board recently approved a $10 million project increasing its greenhouse square footage from 43,000 to 100,000 square feet.
Aurora Cannabis (CSE:ACB)
Aurora’s production facilities are located in Mountain View County, Alberta, near the Rocky Mountains. The company aims to “produce the cleanest, safest medical cannabis available on the market,” and all of its strains are currently offered at $8 per gram.
On June 8, Aurora acquired CanvasRx, the largest medical cannabis patient outreach service in Canada. It also announced a best efforts private placement for gross proceeds of approximately $15 million.
Naturally Splendid (TSXV:NSP,OTCMKTS:NSPDF)
Naturally Splendid has a slightly different focus—rather than being involved in the medical marijuana space, the company offers investors exposure to the hemp-based healthy foods and omega markets. It is the only publicly traded company in the world offering investors exposure in this area.
After securing a nearly $1 million purchase order for hemp food products for Korea Beauty & Health Care back in February, Naturally Splendid reported in May that purchase orders from the country had risen to C$3 million in value. The company is planning to move to larger production facilities (12,000 square feet vs. 6,700 square feet) in response to increased sales opportunities. The move is expected to be complete by July 1 2016.
Naturally Splendid also has a sister company listed on the OTC, Laguna Blends (OTCMKTS:LAGBF), which is focused on the nutritional health benefits of hemp.
Beleave (CSE:BE)
Beleave is still in the review stage for its license to produce cannabis under Canada’s Marijuana for Medical Purposes Regulations (MMPR). However, the company signed a memorandum of understanding (MOU) in March with Ryerson University relating to drug standardization research in March, and also entered a letter of intent (LOI) in April with gDial for the research, development, and licensing of a proprietary drug dosing, detection, and usage-tracking technology.
Beleave has also been endorsed by the City of Hamilton Planning and Economic Development Department.
Golden Leaf Holdings (CSE:GLH)
Listed in Canada but located in Oregon, Golden Leaf Holdings is focused on producing high quality cannabis oils. On May 26, the company announced a new Golden Private Stash product line, a premium solvent-free cannabis oil produced in small batches.
Vodis Pharmacueticals (CSE:VP)
Vodis has medical and recreational marijuana business operations in both Canada and the United States. The company reported successful production cycles for recreational marijuana at its Washington Facilities on April 4, and appointed Sean Côté as the company’s new CEO on May 11.
Get Our Expert Guide to Cannabis Investing FREE!
Download this FREE Special Report, Investing in Medical Cannabis Information about Cannabis and Legal Cannabis Stocks.
THC Biomed (CSE:THC)
Located in Kelowna BC, THC BioMed has been granted permission to conduct research and development for scientific purposes with medicinal marijuana. The company provides scientific and biotechnical services to current and potential licensed producers under MMPR.
On May 26, Health Canada granted TCH BioMed a license to produce fresh marijuana, cannabis oil and cannabis resin.
PharmaCan (TSXV:MJN)
PharmaCan is a merchant bank focused on investing in the Canadian marijuana industry. It also supports the companies in which it invests through management consultation.
Examples of comapnies in which PharmaCan currently holds an interest include In The Zone (100 percent), Whistler Medical Marijuana Company (21.5 percent) and the Peace Naturals Project (27.3 percent).
Calyx Bio-Ventures (TSXV:CYX)
Calyx is an agri-tech company which owns a portfolio of proprietary intellectual property with applications in crop enhancement, as well as a software platform tailored to the advanced indoor agriculture sector.
The company reported in September 2015 that its software subsidiary, Cannigistics Agri-Solutions, had signed two software licensing agreements in just over a week. There has been no news from the company so far in 2016.
Abattis Bioceuticals (CSE:ATT)
Abattis Bioceuticals is a vertically integrated biotechnology company focused on natural health products including cannabis. The company develops natural health products and conducts research and development for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets.
On May 11, Abattis announced it had selected Ingredient Identity as its regulatory management partner. “Abattis’ and its subsidiary companies presented us with one of the most fun and unique opportunities to date in the history of our firm,” said Brandon Griffin, CEO of Ingredient Identity, in a statement. “We created an incredibly comprehensive solution to work closely with the Abattis team now and seamlessly as it grows.”
Emerald Health Botanicals (TSXV:EMH)
Emerald Health Botanicals, previously Emerald Health therapeutics, is a licensed medical marijuana producer under MMPR. Also, as a federal research grant recipient, the company conducts research and development into the characterization of cannabis strains and cultivation technologies. It also collaborates with academic and medical research to help gain further understanding of the effect of cannabis on humans.
Emerald Health announced in November 2015 that it had received a supplemental license from Health Canada to begin producing cannabis oils and capsules. More recently, the company completed a shares for debt transaction at the start of May.
Tinley Beverage (CSE:TNY)
Tinley Beverage is the producer of Hemplify, a drinkable vitality supplement containing hemp extract made from the stalk of industrial hemp. The vegan, sugar free drink is a source of electrolytes, vitamins and Omega 3 fatty acids.
The company reported receiving its first orders for Hemplify products on March 10. The company’s first commercial bottling run for Hemplify is scheduled for mid June.
Cannabix (CSE:BLO)
Finally, on the technology side of things, Cannabix technologies is developing a breathalyzer that detects THC for use by law enforcement. The company’s marijuana breathalyzer is currently under development in partnership with University of Florida chemists. The company’s researchers have confirmed the ability to specifically detect THC at standard temperature and pressure, and have isolated THC and THC-related by-products in controlled simulated breath samples.
On May 11, Cannabix added Dr. Marilyn Huestis to its advisory board, one of the world’s foremost experts on the effects of marijuana use on driving impairment.
Any Canadian marijuana stocks we missed? Let us know in the comments. And don’t forget to follow us @INN_Resource for real-time news updates!
Get Our Expert Guide to Cannabis Investing FREE!
Download this FREE Special Report, Investing in Medical Cannabis Information about Cannabis and Legal Cannabis Stocks.
http://investingnews.com/daily/reso...ana-stocks-mettrum-health-naturally-splendid/
16 Canadian Marijuana Stocks
Here's a look at 16 Canadian marijuana stocks, including everything from hemp to high-tech breathalyzers.
« How to Find the Best Cann…
Teresa Matich • June 13, 2016
Add Comment
Best cannabis
Things could be looking up for the cannabis space, and for Canadian marijuana stocks in particular.
At this year’s United Nations General Assembly Special Session (UNGASS 2016), Canadian health minister Jane Philpott announced that the Liberal government intends to introduce legislation to legalize marijuana in spring of 2017. The move gets Canada one step closer to legalizing cannabis for recreational use, a subject that is no doubt top of mind for investors in Canadian marijuana stocks.
A number of states and provinces in Canada and the US are in various phases of legalization for both medical and recreational marijuana use, making the market confusing for new investors. What’s more, the pot bubble of 2014 serves as a good reminder for investors to do careful due diligence on any potential cannabis investment. Still, there are good opportunities out there for interested investors willing to do their research.
With that in mind, here’s a look at a few publicly traded Canadian marijuana stocks. The list includes cannabis and hemp focused stocks listed on Canadian exchanges.
Get Our Expert Guide to Cannabis Investing FREE!
Download this FREE Special Report, Investing in Medical Cannabis Information about Cannabis and Legal Cannabis Stocks.
Canopy Growth (TSXV:CGC)
One of the larger Canadian marijuana stocks, Canopy holds producers Tweed and Bedrocan under its umbrella. Tweed’s production facility is located in the old Hershey factory in Smith Falls, Ontario.
Near the end of May, Bedrocan stated that it would begin offering same-day delivery services in Toronto. Canopy Growth also announced it would be expanding into Australia as well through a partnership with AusCann Group Holdings.
At the start of June, Canopy announced it had received conditional approval to list on the Toronto Stock Exchange.
Mettrum (TSXV:MT)
One of the first medical cannabis producers in Canada to be licensed under MMPR, Mettrum Health is a vertically integrated provider of cannabis products. It operates three facilities in Ontario with an annual production capacity of 12,000 kilograms. Mettrum offers a range of products in both whole-bud and extract forms.
On May 9, the company received an amendment to its license allowing it to both produce and sell medical cannabis and extracts.
OrganiGram (TSXV:OGI)
As its name suggests, OrganiGram specializes in producing organically grown medical marijuana. The company is licensed under MMPR, and has a production facility located in Moncton, New Brunswick. On June 2, Organigram closed a $10 million bought deal financing and announced the appointment of Peter Amirault to the company’s board of directors.
Aphria (TSXV:APH)
Also licensed under MMPR, Aphria is located in Learnington Ontario, at “Canada’s southernmost point.” The company announced on June 2 that it expects to more than double its growing capacity—the company’s board recently approved a $10 million project increasing its greenhouse square footage from 43,000 to 100,000 square feet.
Aurora Cannabis (CSE:ACB)
Aurora’s production facilities are located in Mountain View County, Alberta, near the Rocky Mountains. The company aims to “produce the cleanest, safest medical cannabis available on the market,” and all of its strains are currently offered at $8 per gram.
On June 8, Aurora acquired CanvasRx, the largest medical cannabis patient outreach service in Canada. It also announced a best efforts private placement for gross proceeds of approximately $15 million.
Naturally Splendid (TSXV:NSP,OTCMKTS:NSPDF)
Naturally Splendid has a slightly different focus—rather than being involved in the medical marijuana space, the company offers investors exposure to the hemp-based healthy foods and omega markets. It is the only publicly traded company in the world offering investors exposure in this area.
After securing a nearly $1 million purchase order for hemp food products for Korea Beauty & Health Care back in February, Naturally Splendid reported in May that purchase orders from the country had risen to C$3 million in value. The company is planning to move to larger production facilities (12,000 square feet vs. 6,700 square feet) in response to increased sales opportunities. The move is expected to be complete by July 1 2016.
Naturally Splendid also has a sister company listed on the OTC, Laguna Blends (OTCMKTS:LAGBF), which is focused on the nutritional health benefits of hemp.
Beleave (CSE:BE)
Beleave is still in the review stage for its license to produce cannabis under Canada’s Marijuana for Medical Purposes Regulations (MMPR). However, the company signed a memorandum of understanding (MOU) in March with Ryerson University relating to drug standardization research in March, and also entered a letter of intent (LOI) in April with gDial for the research, development, and licensing of a proprietary drug dosing, detection, and usage-tracking technology.
Beleave has also been endorsed by the City of Hamilton Planning and Economic Development Department.
Golden Leaf Holdings (CSE:GLH)
Listed in Canada but located in Oregon, Golden Leaf Holdings is focused on producing high quality cannabis oils. On May 26, the company announced a new Golden Private Stash product line, a premium solvent-free cannabis oil produced in small batches.
Vodis Pharmacueticals (CSE:VP)
Vodis has medical and recreational marijuana business operations in both Canada and the United States. The company reported successful production cycles for recreational marijuana at its Washington Facilities on April 4, and appointed Sean Côté as the company’s new CEO on May 11.
Get Our Expert Guide to Cannabis Investing FREE!
Download this FREE Special Report, Investing in Medical Cannabis Information about Cannabis and Legal Cannabis Stocks.
THC Biomed (CSE:THC)
Located in Kelowna BC, THC BioMed has been granted permission to conduct research and development for scientific purposes with medicinal marijuana. The company provides scientific and biotechnical services to current and potential licensed producers under MMPR.
On May 26, Health Canada granted TCH BioMed a license to produce fresh marijuana, cannabis oil and cannabis resin.
PharmaCan (TSXV:MJN)
PharmaCan is a merchant bank focused on investing in the Canadian marijuana industry. It also supports the companies in which it invests through management consultation.
Examples of comapnies in which PharmaCan currently holds an interest include In The Zone (100 percent), Whistler Medical Marijuana Company (21.5 percent) and the Peace Naturals Project (27.3 percent).
Calyx Bio-Ventures (TSXV:CYX)
Calyx is an agri-tech company which owns a portfolio of proprietary intellectual property with applications in crop enhancement, as well as a software platform tailored to the advanced indoor agriculture sector.
The company reported in September 2015 that its software subsidiary, Cannigistics Agri-Solutions, had signed two software licensing agreements in just over a week. There has been no news from the company so far in 2016.
Abattis Bioceuticals (CSE:ATT)
Abattis Bioceuticals is a vertically integrated biotechnology company focused on natural health products including cannabis. The company develops natural health products and conducts research and development for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets.
On May 11, Abattis announced it had selected Ingredient Identity as its regulatory management partner. “Abattis’ and its subsidiary companies presented us with one of the most fun and unique opportunities to date in the history of our firm,” said Brandon Griffin, CEO of Ingredient Identity, in a statement. “We created an incredibly comprehensive solution to work closely with the Abattis team now and seamlessly as it grows.”
Emerald Health Botanicals (TSXV:EMH)
Emerald Health Botanicals, previously Emerald Health therapeutics, is a licensed medical marijuana producer under MMPR. Also, as a federal research grant recipient, the company conducts research and development into the characterization of cannabis strains and cultivation technologies. It also collaborates with academic and medical research to help gain further understanding of the effect of cannabis on humans.
Emerald Health announced in November 2015 that it had received a supplemental license from Health Canada to begin producing cannabis oils and capsules. More recently, the company completed a shares for debt transaction at the start of May.
Tinley Beverage (CSE:TNY)
Tinley Beverage is the producer of Hemplify, a drinkable vitality supplement containing hemp extract made from the stalk of industrial hemp. The vegan, sugar free drink is a source of electrolytes, vitamins and Omega 3 fatty acids.
The company reported receiving its first orders for Hemplify products on March 10. The company’s first commercial bottling run for Hemplify is scheduled for mid June.
Cannabix (CSE:BLO)
Finally, on the technology side of things, Cannabix technologies is developing a breathalyzer that detects THC for use by law enforcement. The company’s marijuana breathalyzer is currently under development in partnership with University of Florida chemists. The company’s researchers have confirmed the ability to specifically detect THC at standard temperature and pressure, and have isolated THC and THC-related by-products in controlled simulated breath samples.
On May 11, Cannabix added Dr. Marilyn Huestis to its advisory board, one of the world’s foremost experts on the effects of marijuana use on driving impairment.
Any Canadian marijuana stocks we missed? Let us know in the comments. And don’t forget to follow us @INN_Resource for real-time news updates!
Get Our Expert Guide to Cannabis Investing FREE!
Download this FREE Special Report, Investing in Medical Cannabis Information about Cannabis and Legal Cannabis Stocks.
http://investingnews.com/daily/reso...ana-stocks-mettrum-health-naturally-splendid/
